CHARLOTTE, N.C. / Mar 13, 2023 / Business Wire / Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has been recognized by Ethisphere®, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies®.
Premier, a member of Ethisphere’s Business Ethics Leadership Alliance™ (BELA), a global community committed to advancing business integrity, has been recognized by Ethisphere as one of the World’s Most Ethical Companies® every year since 2007. Premier is the only honoree in the Business Services category for both 2022 and 2023.
Ethisphere’s 2023 Ethics Index, the collection of publicly traded companies recognized as recipients of this year’s World’s Most Ethical Companies designation, outperformed a comparable index of large-cap companies by 13.6 percentage points over a five-year period.
“Premier is proud to receive this prestigious honor for 16 consecutive years as a testament to our commitment to integrity and meeting the highest ethical standards,” said Michael J. Alkire, President and CEO of Premier. “Improving healthcare, building trust and operating responsibly are embedded in the company’s business and culture – and support our mission to improve the health of communities.”
Premier shares its progress on environmental, social and governance (ESG) practices annually through its corporate sustainability report.
“Today, business leaders face their greatest mandate yet to be ethical, accountable and trusted to drive positive change,” said Erica Salmon Byrne, CEO of Ethisphere. “We continue to be inspired by the World’s Most Ethical Companies honorees and their dedication to integrity, sustainability, governance and community. Congratulations to Premier for earning the World’s Most Ethical Companies designation.”
Methodology & Scoring
Grounded in Ethisphere’s proprietary Ethics Quotient®, the World’s Most Ethical Companies assessment process includes more than 200 questions on culture, environmental, social and governance practices, ethics and compliance activities, diversity, and initiatives to support a strong value chain. The process serves as an operating framework to capture and codify the leading practices of organizations across industries and around the globe.
About Ethisphere
Ethisphere is a global leader in defining and advancing the standards of ethical business practices that fuel corporate character, marketplace trust and business success. Ethisphere has deep expertise in measuring and defining core ethics standards using data-driven insights that help companies enhance corporate character and measure and improve culture. Ethisphere honors superior achievement through its World’s Most Ethical Companies recognition program and provides a community of industry experts with the Business Ethics Leadership Alliance (BELA). More information about Ethisphere can be found at https://ethisphere.com.
About Premier, Inc.
Premier, Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,400 U.S. hospitals and health systems and approximately 250,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.
Last Trade: | US$22.37 |
Daily Change: | 0.13 0.58 |
Daily Volume: | 73,467 |
Market Cap: | US$2.240B |
November 05, 2024 August 19, 2024 February 13, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB